Mutational signatures

Show results for

Unknown (1580)
Genomics (767)
Transcriptomics (153)
Other (26)
Proteomics (13)
Methylation profiling (10)
Genomic (5)
Metabolomics (4)
Models (1)

Organisms

Homo sapiens (424)
Mus musculus (38)
Andropogon gerardi (11)
Bacteria (11)
Canis lupus familiaris (11)
Cnidaria (11)
Cricetulus griseus (11)
Eukaryota (11)
Fasciola (11)
Arabidopsis thaliana (4)
Canis lupus familiaris (4)
Saccharomyces cerevisiae (4)
Drosophila melanogaster (3)
Caenorhabditis elegans (2)
Escherichia coli (2)
Amycolatopsis mediterranei S699 (1)
Escherichia coli APEC O1 (1)
Lactococcus lactis subsp. lactis (1)
Gluconobacter oxydans 621H (1)
Bifidobacterium breve UCC2003 (1)
HIV-1 vector pNL4-3 (1)
Bordetella bronchiseptica (1)
Schizosaccharomyces pombe (1)
Staphylococcus aureus (1)
Streptococcus pneumoniae (1)
Pseudomonas aeruginosa PAO1 (1)
Pseudomonas aeruginosa (1)
Corynebacterium glutamicum ATCC 13032 (1)
Candida albicans (1)
Hepatitis E virus (1)

Organisms

Homo sapiens (155)
Mus musculus (27)
Pseudomonas (2)
Saccharomyces cerevisiae (2)
Canis lupus familiaris (2)
Hepatitis E virus (1)
Ameiurus nebulosus (1)
Severe acute respiratory syndrome coronavirus 2 (1)
Caenorhabditis elegans (1)

Repository

ENA (462)
EGA (276)
geo (138)
biostudies-arrayexpress (76)
pride (11)
dbGaP (5)
MetaboLights (4)
GPMDB (2)
BioModels (1)
EVA (1)
iProX (1)
MassIVE (1)
NODE (1)

Tissue

Cell culture (4)
Blood (2)
Blood cell (2)
Epithelial cell (2)
Hematocyte (1)
Rectum (1)
Cell (1)
Epithelium of pancreatic duct (1)
Kidney (1)
Liver (1)
Lung (1)
Lymph node (1)
Lymphoblast (1)
Malignant cell (1)
Nerve (1)
PanIN cell (1)
Pancreatic duct (1)
Pancreatic ductal adenocarcinoma cell (1)
Permanent cell line cell (1)
Prostate epithelium (1)
Stomach (1)

Disease

Ductal breast cancer (2)
Not Available (2)
Idiopathic myelofibrosis (1)
Breast cancer (1)
Cancer (1)
Leukemia (1)
Lymphoma (1)
Malignant neoplasm of ovary (1)
Malignant peripheral nerve sheath tumor (1)
Non-small cell lung carcinoma (1)
Pancreatic ductal adenocarcinoma (1)
Prostate cancer (1)
Stomach carcinoma (1)

Technology Type

Illumina HiSeq 2000 (15)
Mass Spectrometry (11)
Shotgun proteomics (5)
Mass spectrometry (4)
Affinity purification coupled with mass spectrometry proteomics (4)
Bottom-up proteomics (4)
Illumina HiSeq 2500, ILLUMINA (3)
ILLUMINA, Illumina HiSeq 2500 (3)
ILLUMINA, Illumina HiSeq 2000 (2)
Illumina HiSeq 2500 (2)
Data-dependent acquisition (2)
Top-down proteomics (2)
Illumina HiSeq 2500, ILLUMINA, Illumina MiSeq, HiSeq X Ten (1)
ILLUMINA, Illumina HiSeq 2500, NextSeq 500, Nanostring (1)
ILLUMINA, Illumina HiSeq 2500, HiSeq X Ten, Illumina HiSeq 2000 (1)
Illumina HiSeq 2000, Illumina Infinium HumanMethylation450 BeadChip, Affymetrix expression array, ILLUMINA (1)
Illumina HiSeq 2500, Illumina HiSeq 4000, ILLUMINA, NextSeq 500 (1)
ILLUMINA, Illumina HiSeq 2500, HiSeq X Ten (1)
Illumina HiSeq 2500 (ILLUMINA) (1)
Illumina_450K (1)
Illumina HiSeq 2000, Affymetrics_SNP_6.0-, Illumina Genome Analyzer IIx (1)
Illumina Genome Analyzer, Illumina HiSeq 2000, Illumina MiSeq, Affymetrix_U133plus2- (1)
Illumina Genome Analyzer IIx, Illumina HiSeq 2500, Illumina HiSeq 2000 (1)
Complete Genomics, Illumina Genome Analyzer IIx (1)
Life Tech - Solid (1)
ILLUMINA, Illumina HiSeq 2000 (ILLUMINA), Illumina HiSeq 2000 (1)
Illumina HiSeq 2000, ILLUMINA (1)
Illumina Genome Analyzer II (1)
Gel-based experiment (1)
Immunopeptidomics (1)

Instrument Platform

Illumina HiSeq 2500 (4)
NextSeq 500 (4)
Liquid Chromatography MS - positive - reverse phase (4)
Liquid Chromatography MS - negative - reverse phase (3)
Illumina HiSeq (2)
AB SOLiD 4 System (2)
Illumina Genome Analyzer IIx (2)
Illumina Genome Analyzer II (2)
Illumina MiSeq (2)
Illumina HiSeq 2000 (2)
Instrument (2)
FACSAria III (BD Sciences) (1)
HPC (1)
10x Genomics Chromium (1)
Illumina NovaSeq X (1)
- (1)
Illumina NovaSeq 6000 (1)
Illumina HiSeq 4000 (1)
Illumina (1)
Q Exactive (1)

Publication Date

2025 (29)
2023 (26)
2016 (20)
2015 (18)
2012 (16)
2022 (15)
2021 (15)
2026 (14)
2024 (11)
2018 (10)
2017 (9)
2020 (8)
2013 (8)
2011 (7)
2010 (7)
2014 (6)
2019 (6)
2008 (5)
2007 (2)
2005 (1)

CHEBI ID

CHEBI:229948 (1)
CHEBI:192213 (1)
CHEBI:71182 (1)
CHEBI:131739 (1)
CHEBI:16737 (1)

Metabolite Name

N,N,N-Trimethyl-L-alanyl-L-proline betaine (TMAP) (1)
5-Amino-1,3,4-thiadiazole-2-thiol (1)
Hydroxycotinine (1)
Niacinamide (1)
Creatinine (1)
Hypoxanthine (1)

IsPrivate

False (1)

Submitter Keywords

Machine Learning Model (1)

First Public Date

2016 (114)
2026 (51)
2025 (49)
2023 (49)
2022 (43)
2019 (31)
2020 (30)
2018 (26)
2024 (23)
2021 (22)
2017 (10)
2014 (6)
2015 (5)
2013 (3)

Classification

viruses (2)

Modelling Approach

Other (1)

Study type

Transcription profiling by array (44)
RNA-seq of coding RNA (15)
DNA-seq (4)
Other (2)
ChIP-seq (2)
Methylation profiling by array (2)
RNA-seq of coding RNA from single cells (2)
Unknown experiment type (1)
Genotyping by array (1)
Transcription profiling by RT-PCR (1)
Comparative genomic hybridization by array (1)
RIP-seq (1)

Release Date

2022 (253)
2023 (227)
2021 (213)
2025 (186)
2024 (159)
2020 (143)
2019 (110)
2018 (90)
2017 (60)
2015 (46)
2016 (41)
2012 (26)
2014 (24)
2026 (20)
2013 (15)
2010 (12)
2011 (11)
2008 (9)
2009 (4)
2007 (2)
2005 (2)
2006 (1)
2002 (1)
1999 (1)

Lab affiliation

Division of Cancer Epigenomics, German Cancer Research Center (DKFZ), INF280, 69120 Heidelberg, Germany (2)
1Thoracic and Gastrointestinal Oncology Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA (1)
Assistant Professor, Departments of Oncology & Pathology, McGill University Principal Investigator, Cancer Research Program, MUHC-RI 1001 Decarie Blvd, EM2.2218 514.934.1934 ext 76307 Montréal, Canada (1)
Benjamin A. Garcia, Ph.D., FRSC John McCrea Dickson M.D. Presidential Professor Director of Quantitative Proteomics Penn Epigenetics Institute Department of Biochemistry and Biophysics Smilow Center for Translational Research Perelman School of Medicine University of Pennsylvania Room 9-124 (office) 3400 Civic Center Blvd Philadelphia, PA 19104 215-573-9423 (office) (1)
Division of Cancer Epigenomics, German Cancer Research Center (DKFZ) (1)
Head of Proteomics Unit Spanish National Cancer Research Centre (CNIO) Address: Melchor Fernández Almagro, 3. 28029 Madrid. SPAIN Phone: +34 917 328 000 Ext. 3110 (1)
Institut Curie, Paris Sciences et Lettres Research University, INSERM U934/ CNRS, UMR3215 (1)
OmicVision Biosciences ApS (1)
Professor i molekylærbiologi og faglig leder av PROMEC Institutt for klinisk og molekylær medisin Erling Skjalgssons g 1, aboratoriesenteret * * Laboratoriesenter Norwegian University of Science and Technology Trondheim 7030 Norway ( lab head ) (1)
Sainte-Justine Hospital Research Center (CRCHUSJ) (1)

Previous page
1 / 256
You're on page 1
page 2
page 3
page 4
page 5
page ...
page 256
Next page

Sort by:

Relevance

Page size

Geographic variation of mutagenic exposures in kidney cancer genomes

International differences in the incidence of many cancer types indicate the existence of carcinogen exposures that have not been identified by conventional epidemiology yet potentially make a substantial contribution to cancer burden1. This pertains to clear cell renal cell carcinoma (ccRCC), fo...

2024-03-26 | MTBLS9394 | MetaboLights

Mutational signatures

PRJEB60585 | ENA

mutational signatures of aflatoxin

Genome-scale mutational signatures of aflatoxin in cells, mice and human tumor

PRJEB20736 | ENA

Mutational signatures of colorectal cancers according to distinct computational workflows

PRJEB61897 | ENA

APOBEC3A induces cancer-specific mutational signatures in human genomes

PRJEB13145 | ENA

The repertoire of mutational signatures in human cancer.

Not available

S-EPMC7054213 | biostudies-literature

Exome sequencing of hepatocellular carcinomas identifies new mutational signatures and potential therapeutic targets

Genomic analyses promise to improve tumor characterization in order to optimize personalized treatment for patients with hepatocellular carcinoma (HCC). Exome sequencing analysis of 243 liver tumors revealed mutational signatures associated with specific risk factors, mainly combined alcohol/tobacco...

EGAS00001001002 | EGA

Mutational signatures in colon cancer.

Not available

S-EPMC6889194 | biostudies-literature

Mutational Signatures in Cancer (MuSiCa): a web application to implement mutational signatures analysis in cancer samples.

Not available

S-EPMC6001047 | biostudies-literature

Diffsig: Associating Risk Factors With Mutational Signatures.

Not available

S-EPMC9934616 | biostudies-literature